From: Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway
Parameters | ANXA1 | p-value | ||
---|---|---|---|---|
Low | High | |||
Age (years) | Â | Â | Â | 0.175 |
  ≤ 60 | 108 | 59 | 49 |  |
  > 60 | 304 | 143 | 161 |  |
Gender | Â | Â | Â | 0.119 |
 Male | 304 | 156 | 148 |  |
 Female | 108 | 46 | 62 |  |
Histological grade | Â | Â | Â | 0.034* |
 Low | 21 | 15 | 6 |  |
 High | 388 | 185 | 203 |  |
Tumor depth | Â | Â | Â | 0.055 |
 T0–T2 | 124 | 67 | 57 |  |
 T3–T4 | 255 | 111 | 144 |  |
Lymph node metastasis | Â | Â | Â | 0.143 |
 N0 | 239 | 123 | 116 |  |
 N1–N3 | 131 | 57 | 74 |  |
Distant metastasis | Â | Â | Â | 0.918 |
 M0 | 196 | 110 | 86 |  |
 M1 | 11 | 6 | 5 |  |
Clinical stage | Â | Â | Â | 0.008* |
 I + II | 133 | 78 | 55 |  |
 III + IV | 277 | 124 | 153 |  |